Terms: = Uterine cancer AND NCOR2, SMRTE-tau, 9612, ENSG00000196498, SMRTE, TNRC14, TRAC-1, SMRT, CTG26, TRAC1 AND Treatment
4 results:
1. [treatment and prognosis analysis of 488 patients with FIGO 2018 stage Ⅲc squamous cervical cancer].
Feng T; Shou HF; Yuan SH; Tang HR; Lyu XJ; Yin ZM; Lou HM; Ni J
Zhonghua Fu Chan Ke Za Zhi; 2023 May; 58(5):359-367. PubMed ID: 37217343
[No Abstract] [Full Text] [Related]
2. Tailoring adjuvant radiotherapy for stage IB-IIA node negative cervical carcinoma after radical hysterectomy and pelvic lymph node dissection using the GOG score.
Yeo RM; Chia YN; Namuduri RP; Yap SP; Soong YL; Yam PK; Lim TY; Khoo-Tan HS
Gynecol Oncol; 2011 Nov; 123(2):225-9. PubMed ID: 21782226
[TBL] [Abstract] [Full Text] [Related]
3. Up-regulation of nuclear receptor corepressor (NCoR) in progestin-induced growth suppression of endometrial hyperplasia and carcinoma.
Kashima H; Horiuchi A; Uchikawa J; Miyamoto T; Suzuki A; Ashida T; Konishi I; Shiozawa T
Anticancer Res; 2009 Apr; 29(4):1023-9. PubMed ID: 19414341
[TBL] [Abstract] [Full Text] [Related]
4. A structural and in vitro characterization of asoprisnil: a selective progesterone receptor modulator.
Madauss KP; Grygielko ET; Deng SJ; Sulpizio AC; Stanley TB; Wu C; Short SA; Thompson SK; Stewart EL; Laping NJ; Williams SP; Bray JD
Mol Endocrinol; 2007 May; 21(5):1066-81. PubMed ID: 17356170
[TBL] [Abstract] [Full Text] [Related]
